This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Healthy
and you are
between 18 and 65
years old
Phase
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The study to be performed will utilize already FDA-approved marketed products in healthy adults for the purpose to generate data for establishing rate of drug delivery of Transderm Scop® TDDS (transdermal drug delivery system) in healthy adults and to ensure safety of individuals utilizing these types of products.

Provided treatments

  • Drug: Transderm Scop®
  • Drug: Intravenous scopolamine hydrobromide
Tris trial is registered with FDA with number: NCT03029650. The sponsor of the trial is University of Iowa and it is looking for 29 volunteers for the current phase.
Official trial title: